Scalable Noise Mining in Long-Term Electrocardiographic Time-Series to Predict Death Following Heart Attacks Chih-Chun Chia, Zeeshan Syed University of.

Slides:



Advertisements
Similar presentations
INTRINSIC RV Trial Presented at The Heart Rhythm Society Meeting May 2006 Presented by Dr. Brian Olshansky Inhibition of Unnecessary RV Pacing with AV.
Advertisements

 Used three-lead ECG data from 26 patients admitted to hospitals following non- ST-elevation acute coronary syndrome.  Applied three different nonlinear.
Cardiovascular Disaster in Hemodialysis patients
Jennifer Cohen, MD, Heather Costa, PhD, Robert Russo, MD, PhD, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, CA The MagnaSafe Registry:
Primary Prevention ICD Therapy: Tools to Enhance Guideline Compliance By: Margaret S. Thomas, RN,CVRN Michael J. Mirro, MD Alicia S. Floor, AS,RN, Rob.
Prediction Models in Medicine Clinical Decision Support The Road Ahead Chapter 10.
Implantable Cardioverter Defibrillator Rebecca Boduch Biomedical Engineering University of Rhode Island.
Yujun Guo Kent State University August PRESENTATION A Binarization Approach for CT-MR Registration Using Normalized Mutual Information.
MEDICAL RECORDS MANAGEMENT IN EYE CARE SERVICES 6.International classification of Disease & Procedures and the method of Indexing data.
LIFE SAVING TECHNOLOGY THAT HAVE ARISEN AS A RESULT OF IMPROVED UNDERSTANDING OF THE CIRCULATORY SYSTEM (ARTIFICIAL HEART VALVES, ECG AND ARTIFICIAL BLOOD)
Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure Adrian F. Hernandez, MD, MHS; Gregg.
Renal function and clinical outcomes of patients undergoing ICD and CRTD implantation- Data from the Israeli ICD Registry Alon Eisen, Mahmoud Souleiman,
Devices and the older patient with syncope Michael Gammage, Reader in Cardiovascular Medicine MHRA Committee for Safety of Devices.
Acknowledgements Contact Information Anthony Wong, MTech 1, Senthil K. Nachimuthu, MD 1, Peter J. Haug, MD 1,2 Patterns and Rules  Vital signs medoids.
IRIS Post-hoc Analysis Background IRIS compared the safety and efficacy of early ICD implantation with medical treatment alone in 898 patients at high.
Multiple Arterial Bypass Grafting Should Be Routine Robert F Tranbaugh, David J Lucido, Kamellia R Dimitrova, Darryl M Hoffman, Charles M Geller, John.
Heart Failure Devices: Staying Connected Lisa D. Rathman, MSN, CRNP, CCRN, CHFN The Heart Group of Lancaster General Health Lancaster, PA.
A Claims Database Approach to Evaluating Cardiovascular Safety of ADHD Medications A. J. Allen, M.D., Ph.D. Child Psychiatrist, Pharmacologist Global Medical.
Agenda Introduction to established biomarker, HbA1c Objectives
? What more will it take to turn the tide of treatment for angina patients from a PCI-first to an optimal medical therapy– first approach? 1.
Baseline Characteristics of the Patients* - Part I The ONTARGET Investigators. N Engl J Med 2008 [Epub on Mar 31]
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
Increased Patient Device Concerns But Not General Anxiety in Patients with a Secondary Indication for the ICD Susanne S. Pedersen, Professor of Cardiac.
Physiological Data Analysis of Neuro-Critical Patients Using Markov Models By Shashwat Bhoop sb3758.
The CHART-2 Study (The Chronic Heart Failure Analysis and Registry in the Tohoku District 2) Source Shiba N, Nochioka K, Miura M, et al. Trend of westernization.
R1 강민혜 / prof. 전숙. Introduction Patients with type 2 diabetes have a greatly increased risk of cardiovascular events. The morbidity and mortality related.
Zhaoxia Fu, Yan Han Measurement Volume 45, Issue 4, May 2012, Pages 650–655 Reporter: Jing-Siang, Chen.
Date of download: 6/26/2016 From: Comparative Effectiveness of Cardiac Resynchronization Therapy With an Implantable Cardioverter- Defibrillator Versus.
Pharmacy in Public Health: Describing Populations Course, date, etc. info.
Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:
You Zhang, Jeffrey Meyer, Joubin Nasehi Tehrani, Jing Wang
Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness.
Circ Arrhythm Electrophysiol
Figure 1 Study flow chart.
Copyright © 2000 American Medical Association. All rights reserved.
Brugada’s Syndrome and Sudden Cardiac Death
The role of treadmill exercise testing in women
Hypertrophic Cardiomyopathy
Preventing SCD With a WCD: Reviewing the Results of the VEST Trial
Addressing Patients at High Risk for SCA
Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.
Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection  Derek V. Exner, MD, MPH, David.
Volume 5, Issue 4, Pages (April 2008)
The Prevalence of and Contributed Risk Factors of Cardiovascular Diseases among People with Spinal Cord Injury: A Retrospective Study Ramzi Alajam.
Cardiac Issues: Atrial fibrillation, Pacemakers, Stents, and Rehab
Updated Guideline Recommendations for the Definitive Diagnosis of Unexplained Syncope.
Goals Significance Results Uncorrected MAR Corrected
Tom F. Brouwer et al. JACEP 2016;2:
Belinda Gray et al. JCHF 2013;1:
David F. Katz et al. JACEP 2016;j.jacep
Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.
Volume 11, Issue 2, Pages (February 2014)
Mahesh Anantha Narayanan et al. JACEP 2017;3:
Elevated Admission Plasma Glucose Following ACS
Prabhat Kumar et al. JACEP 2016;j.jacep
Repeated molecular genetic analysis in Brugada syndrome revealed a novel disease- associated large deletion in the SCN5A gene  Anders Krogh Broendberg,
David F. Katz et al. JACEP 2017;3:20-28
Failure of ICD therapy in lethal arrhythmogenic right ventricular cardiomyopathy type 5 caused by the TMEM43 p.Ser358Leu mutation  Kasper Aalbæk Kjærgaard,
Volume 11, Issue 1, Pages (January 2014)
Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep
Volume 11, Issue 3, Pages (March 2014)
Inappropriate shocks in a patient with a subcutaneous implantable cardioverter- defibrillator  Sana M. Al-Khatib, MD, MHS, FHRS, Sasmrita Belbase, NP,
Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulators  Thor Tejada, MD, Faisal.
Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep
Saadia Sherazi et al. JACEP 2015;1:74-80
Results of comparisons of treatments in the network.
Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.
(A). (A). Kaplan-Meier plot of event-free survival in 27 LMNA mutation carriers and 78 DCM control patients. Death, heart transplantation, resuscitation.
QRISK 3 – Clare Hawley - Summary slide
Survival free of atrial fibrillation after implantation of an implantable cardioverter defibrillator in our series (151 patients): overall population (solid.
Presentation transcript:

Scalable Noise Mining in Long-Term Electrocardiographic Time-Series to Predict Death Following Heart Attacks Chih-Chun Chia, Zeeshan Syed University of Michigan Presenter: Sen Jiao Mar. 19, 2015

Objective Improve an algorithm for mining useful information in electrocardiogram (ECG) to identify patients at an increased risk of death following heart attacks.

Introduction Heart disease: 34% of all deaths each year in the U.S, 1 death in every 38 seconds Reducing mortality: inability to match patients to treatments that are most appropriate for individual risk. Implantable cardioverter defibrillator (ICD) Current decision-making methods fail to prescribe ICD to the majority.

Introduction Biomarkers: to estimate patient risk and to match patients to treatments. Blood-based measurements, medical imaging: limited to available information. ECG may contain subtle but useful information, commonly perceived as noise. Morphologic variability (MV) in ECG: indicator of heart function.

Background Electrocardiogram (ECG)

Background Pathophysiology

Background Morphological Variability (MV)

Background Dynamic Time-Warping (DTW)

Background Dynamic Time-Warping (DTW)

Background Constrained DTW: prevent biologically implausible alignments – Boundary Conditions – Continuity – Monotonicity

Background Constrained DTW

Background Power Spectral Density – Lomb-Scargle periodogram

Overall Flow Chart O(pn 2 )

Adaptive Down-sampling (ADAP) PAA, FastDTW,ADAP

DTW with ADAP

Evaluation 4-day continuous ECG data recorded Patients follow-up for 90 days for cardiovascular death Evaluate MV, MV measured with PAA, MV measured with ADAP Measure areas under the receiver operating characteristic curves (AUROCs)

Results

Conclusion ADAP substantially reduces runtime while providing similar performance to the basic MV algorithm that is not optimized for large volumes of data. The use of ADAP leads to more accurate performance than downsampling through the commonly used approach of PAA.

Q&A Thank you!